LL-37 FAQ for Laboratory Researchers
LL-37 is a 37-amino-acid cathelicidin-derived peptide widely investigated in cellular biology, immunology, and membrane-disruption assays. This comprehensive technical FAQ provides laboratory researchers with analytical guidelines regarding LL-37 sequence structure, handling protocols, reconstitution, storage stability, and quality control specifications.
Quick answer
LL-37 is a 37-amino-acid cathelicidin-derived peptide widely investigated in cellular biology, immunology, and membrane-disruption assays. This comprehensive technical FAQ provides laboratory researchers with analytical guidelines regarding LL-37 sequence structure, handling protocols, reconstitution, storage stability, and quality control specifications.
Key takeaways
- [LL-37](/research-peptides/ll-37) represents the sole human member of the cathelicidin family of host defense peptides.
- In cell culture models, [LL-37](/research-peptides/ll-37) demonstrates pleiotropic activity by serving as a ligand for various cell-surface receptors.
- When designing comparative bioassays, researchers frequently evaluate [LL-37](/research-peptides/ll-37) alongside other immunomodulatory or tissue-active research compounds.
- Reconstituting synthetic [LL-37](/research-peptides/ll-37) requires careful consideration of its hydrophobic and cationic properties.
Introduction to Cathelicidin LL-37 in Laboratory Settings
LL-37 represents the sole human member of the cathelicidin family of host defense peptides. Derived via extracellular cleavage from the C-terminal end of the hCAP18 pro-protein by proteinase 3, the active 37-residue sequence (LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES) exhibits an amphipathic alpha-helical conformation upon interaction with lipid bilayers. In controlled biochemical environments, researchers utilize the LL-37 research peptide to investigate innate immune signaling pathways, bacterial membrane permeabilization, and chemokine receptor transactivation.
Because LL-37 carries a net positive charge (+6 at physiological pH) due to an abundance of lysine and arginine residues, its secondary structure folds into a distinct amphiphilic helix upon contact with anionic membrane lipids. Preclinical assays evaluate how this structural arrangement allows the peptide to insert into lipid microdomains, promoting pore formation or membrane micellization. Investigating these physical parameters requires high-purity material manufactured under strict quality control standards.
Primary Receptor Targets and In Vitro Mechanisms
In cell culture models, LL-37 demonstrates pleiotropic activity by serving as a ligand for various cell-surface receptors. Preclinical literature emphasizes its high-affinity interaction with Formyl Peptide Receptor-like 1 (FPR2/ALX), a G-protein coupled receptor expressed on neutrophils, monocytes, and epithelial cells. Binding to FPR2/ALX initiates intracellular calcium mobilization, extracellular signal-regulated kinase (ERK) phosphorylation, and cell migration in chemotaxis assays.
Additionally, in vitro research models examine LL-37 for its capacity to scavenge lipopolysaccharide (LPS) directly within solution. By binding the lipid A moiety of endotoxins with high affinity, LL-37 blocks LPS from engaging TLR4/MD-2 receptor complexes on macrophages, thereby blunting downstream NF-κB activation and pro-inflammatory cytokine expression. To review broader literature on host defense mechanisms, explore the PX1 research library.
Comparative Analysis: LL-37 vs. Other Host Defense and Tissue Peptides
When designing comparative bioassays, researchers frequently evaluate LL-37 alongside other immunomodulatory or tissue-active research compounds. While LL-37 acts primarily as an amphipathic host defense peptide targeting membrane integrity and FPR2 signaling, peptides such as Thymosin Alpha-1 exert systemic immunomodulatory effects via Toll-like receptor pathways without direct lytic activity against lipid membranes. Furthermore, tripeptide constructs such as KPV exhibit targeted anti-inflammatory signaling through α-MSH receptors rather than structural membrane insertion.
In extracellular matrix and tissue remodeling assays, investigators often contrast the cationic membrane interactions of LL-37 with signaling peptides like BPC-157 and TB-500. While BPC-157 modulates VEGF and nitric oxide pathways to facilitate cellular migration, and TB-500 sequesters G-actin to promote cytoskeletal reorganization, LL-37 acts through dual physical (membrane disruptor) and receptor-mediated (FPR2 transactivation) pathways. Understanding these distinct mechanisms allows research teams to select the appropriate control or co-treatment compound for specific cell culture assays.
Laboratory Reconstitution Protocols and Solvent Compatibility
Reconstituting synthetic LL-37 requires careful consideration of its hydrophobic and cationic properties. Lyophilized LL-37 should initially be brought to room temperature in a desiccated environment to prevent atmospheric condensation inside the vial. For primary stock solutions, sterile endotoxin-free water or 0.1% acetic acid in sterile water is recommended. Initial solubilization in slightly acidic aqueous solutions prevents hydrophobic self-aggregation that can occur at neutral or basic pH values.
Once completely dissolved in primary aqueous solvent, working solutions may be diluted into phosphate-buffered saline (PBS) or culture media immediately prior to experimental application. Due to the high adsorption tendency of cationic peptides to hydrophobic plastic surfaces, researchers should utilize low-binding polypropylene tubes and pipette tips. Avoid vortexing solutions vigorously; gentle inversion or mild pipetting ensures complete dissolution without inducing peptide shear or foam formation.
Storage Dynamics and Stability Parameters
In its lyophilized powder form, LL-37 maintains long-term structural stability when stored at -20°C or -80°C in a dry environment shielded from direct light exposure. Under these conditions, chemical degradation such as methionine oxidation or peptide bond hydrolysis is minimized. Lyophilized vials supplied by PX1 Research are sealed under inert gas to maximize shelf life during laboratory storage.
Following reconstitution, liquid aliquots should be stored at -80°C for optimal preservation. Repeated freeze-thaw cycles must be rigorously avoided, as phase transitions accelerate peptide aggregation and precipitation out of solution. Working aliquots stored at 4°C should be utilized within 48 to 72 hours. For extended experimental series, preparing single-use aliquots at concentrations of 1 mg/mL in low-binding tubes ensures consistent assay conditions.
Analytical Quality Control: HPLC, MS, and Endotoxin Testing
High-performance liquid chromatography (HPLC) and mass spectrometry (MS) represent the gold standards for verifying the identity and chemical purity of synthetic LL-37. Revers-phase HPLC confirms chemical purity by measuring the relative peak area of the target 37-mer sequence against synthetic truncations or deletion sequences. Mass spectrometry (electrospray ionization or MALDI-TOF) verifies the exact molecular weight (approximately 4493.3 Da for the native sequence) to ensure correct amino acid assembly.
For cell culture and immunological assays, endotoxin contamination presents a significant confounding variable. Residual lipopolysaccharides from synthesis or purification reagents can alter baseline TLR4 signaling. PX1 Research subjects every lot of LL-37 to rigorous chromogenic LAL (Limulus Amebocyte Lysate) testing to confirm endotoxin levels remain below strictly controlled thresholds (<0.1 EU/µg), ensuring non-confounded experimental results.
Research Applications in In Vitro and Animal Models
In preclinical model systems, researchers utilize LL-37 to evaluate diverse biological phenomena ranging from bacterial biofilm disruption to angiogenesis regulation. In vitro biofilm assays examine how sub-inhibitory concentrations of LL-37 inhibit bacterial attachment and alter extracellular polymeric substance (EPS) matrix formation. These studies help map physical interactions between cationic alpha-helices and microbial cell walls.
In mammalian cell models, LL-37 is investigated for its role in modulating wound re-epithelialization and vascular endothelial growth factor (VEGF) expression. Keratinocyte migration assays evaluate FPR2-dependent signaling cascades, while co-culture models examine how LL-37 regulates macrophage polarization between M1 and M2 phenotypes. Researchers interested in broader peptide categories can browse the full catalog of research peptides available for in vitro studies.
Sourcing and Procurement Standards for Research Institutions
Procuring high-grade reagents is critical for maintaining reproducible experimental data across academic and industrial research laboratories. Substandard peptide synthesis can introduce hydrophobic impurities, racemized amino acids, or residual organic solvents (such as trifluoroacetic acid) that distort biological assays. PX1 Research synthesizes peptides in ISO 17025 accredited, GMP-compliant facilities located within the United States.
Every batch of LL-37 is accompanied by a lot-specific Certificate of Analysis (COA) detailing raw HPLC traces, mass spectra, and quantitative endotoxin levels. For large-scale studies or high-throughput screening projects, research institutions can access specialized options via wholesale lab accounts, ensuring batch consistency and uninterrupted supply lines.
Frequently Asked Questions
What is the primary mechanism of action studied for LL-37 in vitro?
Preclinical in vitro studies focus on LL-37's dual mechanisms: direct physical disruption of anionic lipid bilayers via amphipathic alpha-helical insertion, and receptor-mediated signaling through GPCRs such as Formyl Peptide Receptor 2 (FPR2/ALX).
How should LL-37 peptide powder be stored upon delivery?
Lyophilized LL-37 powder should be stored at -20°C or -80°C in a desiccated container away from light. Upon receipt, allow the vial to equilibrate to room temperature before opening to prevent moisture accumulation inside the vial.
What is the optimal solvent for reconstituting LL-37?
LL-37 reconstitutes best in sterile endotoxin-free water or 0.1% dilute acetic acid to create a concentrated primary stock solution. Once solubilized, the solution can be diluted into working buffers or culture media immediately prior to use.
Why is endotoxin testing critical for LL-37 research?
Because LL-37 is frequently used in immunological and cell signaling assays, trace endotoxin (LPS) contamination can falsely stimulate TLR4 pathways, masking or altering the true biological effects of the peptide. PX1 Research verifies endotoxin levels are < 0.1 EU/µg per lot.
What purity level is required for LL-37 cellular assays?
A purity level of ≥ 95% verified by reverse-phase HPLC is recommended for quantitative in vitro bioassays to ensure that synthetic deletion sequences or chemical impurities do not confound cellular responses.
How does LL-37 compare to Thymosin Alpha-1 in immunological studies?
LL-37 is an amphipathic cationic peptide that directly interacts with bacterial and cell membranes and binds FPR2/ALX receptors. In contrast, Thymosin Alpha-1 acts primarily as a systemic immune response modulator via TLR pathways without lytic membrane activity.
Can reconstituted LL-37 undergo multiple freeze-thaw cycles?
No. Repeated freeze-thaw cycles cause hydrophobic aggregation and physical degradation of LL-37. Reconstituted stock solutions should be divided into single-use working aliquots and stored at -80°C.
What equipment is used to verify LL-37 chemical identity?
Electrospray Ionization Mass Spectrometry (ESI-MS) or MALDI-TOF mass spectrometry is used to confirm the exact molecular mass (4493.3 Da), while RP-HPLC verifies analytical purity and chromatographic homogeneity.
Does PX1 Research provide a Certificate of Analysis with LL-37?
Yes. Every lot of LL-37 supplied by PX1 Research includes a lot-specific Certificate of Analysis (COA) containing HPLC chromatograms, Mass Spectrometry results, and LAL endotoxin test data.
What container materials should be used when handling LL-37 solutions?
Due to its cationic nature and amphipathic helix structure, LL-37 can adhere to standard glass or hydrophobic plastic. Low-binding polypropylene tubes and pipette tips should be utilized to minimize material loss.
What is the molecular weight and sequence length of LL-37?
LL-37 consists of 37 amino acid residues with a theoretical molecular weight of approximately 4493.3 Da and a net charge of +6 at neutral pH.
Where is PX1 Research LL-37 manufactured and shipped from?
PX1 Research peptides are synthesized in ISO 17025 accredited, GMP-compliant facilities in the USA and shipped directly from fulfillment centers located in California and Arizona with same-day dispatch for orders placed Monday through Friday.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.